|
|
Index of Articles From AIDSinfo
In English
- Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (PDF) (November 3, 2008)
To download PDA version, click here.
- What's New in the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (November 3, 2008)
- Table 6: Antiretroviral Therapy for Treatment-Naive Patients (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 7: Advantages and Disadvantages of Antiretroviral Components Recommended as Initial Antiretroviral Therapy (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 8: Antiretroviral Components Not Recommended as Initial Therapy (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 9: Antiretroviral Regimens or Components That Should Not Be Offered at Any Time (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 12: Strategies to Improve Adherence to Antiretroviral Therapy (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 13: Antiretroviral Therapy-Associated Adverse Effects and Management Recommendations (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 14: Drugs That Should Not Be Used With PI, NNRTI, or CCR5 Antagonist Antiretrovirals (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15a: Drug Interactions Between Protease Inhibitors (PIs) and Other Drugs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15b: Drug Interactions Between NNRTIs and Other Drugs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15c: Drug Interactions Between NRTIs and Other Drugs (Including Antiretroviral Agents) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15d-e: Drug Interactions Between CCR5 Antagonists, Integrase Inhibitors and Other Drugs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 16a: Interactions Among Protease Inhibitors (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 16b: Interactions between NNRTIs, Maraviroc, and PIs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Table 2: Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Table 3: Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Table 4: Characteristics of Protease Inhibitors (PIs) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Tables 5-7: Characteristics of Fusion and Integrase Inhibitors and CCR5 Antagonists (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (PDF) (July 29, 2008)
To download PDA version, click here.
- Supplement I: Pediatric Antiretroviral Drug Information (PDF) (July 29, 2008)
Supplement to the pediatric guidelines; to download PDA version, click here.
- Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States (PDF) (July 8, 2008)
To download PDA version, click here.
- DHHS Adults and Adolescents Antiretroviral Treatment Guidelines Panel's Communication Regarding Abacavir (April 4, 2008)
To read PDF, click here.
- Supplement II: Managing Complications of HIV Infection in HIV-Infected Children on Antiretroviral Therapy (PDF) (February 28, 2008)
Supplement to the pediatric guidelines; to download PDA version, click here.
- Supplement III: Adverse Drug Effects (PDF) (February 28, 2008)
Supplement to the pediatric guidelines; to download PDA version, click here.
- HIV Treatment Regimen Failure (February 2008)
To read PDF, click here.
- Changing My HIV Treatment Regimen (February 2008)
To read PDF, click here.
- What Is Treatment Adherence? (February 2008)
To read PDF, click here.
- Is My Treatment Regimen Working? (February 2008)
To read PDF, click here.
- Starting Anti-HIV Medications (February 2008)
To read PDF, click here.
- Testing HIV Positive -- Do I Have AIDS? (February 2008)
To read PDF, click here.
- Understanding HIV Prevention (February 2008)
To read PDF, click here.
- Recommended HIV Treatment Regimens (February 2008)
To read PDF, click here.
- HIV During Pregnancy, Labor and Delivery, and After Birth (January 2008)
Health information for HIV-positive pregnant women.
To read PDF, click here.
- Adhering to My HIV Treatment Regimen (December 2007)
To read PDF, click here.
- Seeing an HIV Doctor (December 2007)
To read PDF, click here.
- Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy (PDF) (November 2, 2007)
Supplement to the perinatal guidelines; to download PDA version, click here.
- Entecavir in Hepatitis B Virus (HBV)/HIV Co-Infected Patients (April 30, 2007)
Supplement to the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents -- October 10, 2006
To read PDF, click here.
- Update on the New York City "Superbug" (August 11, 2006)
- Antiretroviral Formulations (PDF) (August 2006)
- Recommended Immunizations for HIV-Positive Adults (June 2006)
To read PDF, click here.
- Recommendations for Non-HIV-Specialized Providers Caring for Displaced HIV-Infected Residents from the Hurricane Disasters (September 23, 2005)
To read PDF, click here.
- What Is an HIV/AIDS Clinical Trial? (September 2005)
To read PDF, click here.
- The HIV Life Cycle (May 2005)
To read PDF, click here.
- Hyperglycemia (May 2005)
To read PDF, click here.
- Lipodystrophy (May 2005)
To read PDF, click here.
- Skin Rash (May 2005)
To read PDF, click here.
- Osteonecrosis, Osteopenia and Osteoporosis (May 2005)
To read PDF, click here.
- Hepatotoxicity (May 2005)
To read PDF, click here.
- Lactic Acidosis (May 2005)
To read PDF, click here.
- Hyperlipidemia (May 2005)
To read PDF, click here.
- FDA Approves Generic Formulation of Didanosine (ddI) Delayed Release Capsules (December 3, 2004)
- Glossary of HIV/AIDS-Related Terms (June 1999)
To read PDF, click here.
- Suggestions for Taking the Liquid Formulation of Ritonavir (August 21, 1998)
- HIV Protease Inhibitors & You (December 1997)
- Developing Options for Perinatal HIV Prevention in the Developing World (June 1997)
- Understanding Viral Load (March 1997)
- Caring for Someone With AIDS at Home: A Guide
En Español
|
Advertisement
|
